Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 175 of 275 entries
View as:

Recombinant Follicle Stimulating Hormone (FSH) (Gonal-f®): Use in Ovulation Induction

Phase: N/A Priority: Normal
NCT ID: NCT01081626 Org: User:
Start: 03/31/09 End: 03/31/11 Due: 03/31/12

Efalizumab for Treatment of Patients With Moderate to Severe Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT00442650 Org: User:
Start: 01/31/04 End: 12/31/05 Due: 12/31/06

Cross-over Study to Evaluate the Palatability of New Orally Disintegrating Tablets (ODTs) of Praziquantel (PZQ) and L-PZQ Versus Current PZQ Tablets in African Children Age 6-11 Years

Phase: N/A Priority: Normal
NCT ID: NCT02315352 Org: User:
Start: 04/30/15 End: 05/31/15 Due: 05/31/16

Sprifermin (AS902330) in Cartilage Injury Repair (CIR)

Phase: N/A Priority: Normal
NCT ID: NCT01066871 Org: User:
Start: 03/31/10 End: 04/30/13 Due: 04/30/14

A Postmarketing Surveillance (PMS) Study to Evaluate the Extent to Which Patient Compliance is Influenced by Use of a Variable Titration Regimen at the Start of Treatment of Relapsing Multiple Sclerosis (MS) With Interferon Beta 1a (Rebif®)

Phase: N/A Priority: Normal
NCT ID: NCT01142492 Org: User:
Start: 01/31/05 End: 07/31/08 Due: 07/31/09

r-hLIF for Improving Embryo Implantation in IVF

Phase: N/A Priority: Normal
NCT ID: NCT00504530 Org: User:
Start: 09/30/01 End: 04/30/02 Due: 04/30/03

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Columbia

Phase: N/A Priority: Normal
NCT ID: NCT02208076 Org: User:
Start: 07/31/14 End: 12/31/15 Due: 12/31/16

A Japanese Phase 1 Trial of c-Met Inhibitor MSC2156119J in Subjects With Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01832506 Org: User:
Start: 04/30/13 End: 10/31/14 Due: 10/31/15

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Austria

Phase: N/A Priority: Normal
NCT ID: NCT01296425 Org: User:
Start: 07/31/11 End: 12/31/15 Due: 12/31/16

Bioequivalence Trial of Concor AM® vs Bisoprolol and Amlodipine in Chinese Participants

Phase: N/A Priority: Normal
NCT ID: NCT03226275 Org: User:
Start: 08/09/17 End: 09/09/17 Due: 09/09/18

Determine the Improvement in Activity Status/Quality of Life (QoL) of Patients With Rheumatoid Arthritis (RA) During Treatment With Lodotra (Prednisone)

Phase: N/A Priority: Normal
NCT ID: NCT01075711 Org: User:
Start: 04/30/09 End: 11/30/10 Due: 11/30/11

ATX-MS-1467 in Multiple Sclerosis

Phase: N/A Priority: Normal
NCT ID: NCT01973491 Org: User:
Start: 02/28/14 End: 04/30/16 Due: 04/30/17

RESTORE: Raptiva® (Efalizumab) Evaluation of Safety and Treatment Optimization

Phase: N/A Priority: Normal
NCT ID: NCT00402818 Org: User:
Start: 05/31/06 End: 07/31/09 Due: 07/31/10

A Study of EMD525797 in Solid Tumor Patients in Japan

Phase: N/A Priority: Normal
NCT ID: NCT01327313 Org: User:
Start: 01/31/11 End: 10/31/12 Due: 10/31/13

Evaluation of the Onset of Action in Highly Active MS (MAGNIFY)

Phase: N/A Priority: Normal
NCT ID: NCT03364036 Org: User:
Start: 05/28/18 End: 02/21/22 Due: 02/21/23

An Observational Study Comparing Multiple Sclerosis International Quality of Life Questionnaire (MusiQoL) and Multiple Sclerosis Quality of Life-54 Instrument (MSQOL-54) in Relapsing Multiple Sclerosis (RMS) Patients on Long-term Rebif® Therapy

Phase: N/A Priority: Normal
NCT ID: NCT01141751 Org: User:
Start: 09/30/05 End: 06/30/11 Due: 06/30/12

Relative Bioavailability Trial of Oral Dispersible Praziquantel Tablets in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02325713 Org: User:
Start: 01/31/15 End: 03/31/15 Due: 03/31/16

A Study Using Micronised Progesterone (Crinone® 8%) in the Luteal Phase Support of Women Undergoing in Vitro Fertilisation (IVF) and Embryo Transfer (ET)

Phase: N/A Priority: Normal
NCT ID: NCT01081652 Org: User:
Start: 05/31/04 End: 05/31/05 Due: 05/31/06

Study to Evaluate the Efficacy and Safety of FOLFOX-4 Plus Cetuximab Versus UFOX Plus Cetuximab.

Phase: N/A Priority: Normal
NCT ID: NCT00439517 Org: User:
Start: 02/28/07 End: 05/31/12 Due: 05/31/13

Atacicept in Combination With Rituximab in Subjects With Rheumatoid Arthritis (August III)

Phase: N/A Priority: Normal
NCT ID: NCT00664521 Org: User:
Start: 03/31/08 End: 10/31/10 Due: 10/31/11

Prednisone Timed-Release Tablet (TRT) Study: Modified-Release (MR) Formulation of Prednisone Compared to Standard Immediate-Release (IR) Prednisone in Participants With Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT00146640 Org: User:
Start: 08/31/04 End: 01/31/07 Due: 01/31/08

CLEAR Study: Clinical Experience Acquired With Raptiva Study

Phase: N/A Priority: Normal
NCT ID: NCT00256139 Org: User:
Start: 03/31/03 End: 10/31/04 Due: 10/31/05

Cilengitide in Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN)

Phase: N/A Priority: Normal
NCT ID: NCT00705016 Org: User:
Start: 10/31/08 End: 06/30/13 Due: 06/30/14

Raptiva in Palm and Sole Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT00972543 Org: User:
Start: 09/30/08 End: - Due: -

M7583 Relative Bioavailability of Tablet Compared to Powder-in-capsule

Phase: N/A Priority: Normal
NCT ID: NCT03297983 Org: User:
Start: 10/09/17 End: 12/06/17 Due: 12/06/18